NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $531 | +4.7% | 12,769 | +22.5% | 0.00% | -50.0% |
| Q2 2023 | $507 | -12.4% | 10,426 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $579 | +38.2% | 10,426 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $419 | -99.9% | 10,426 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $457,000 | +23.8% | 10,426 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $369,000 | -13.0% | 10,426 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $424,000 | -56.5% | 10,426 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $974,000 | -16.2% | 10,426 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $1,162,000 | -1.9% | 10,426 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,184,000 | +11.8% | 10,426 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,059,000 | +2.0% | 10,426 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $1,038,000 | +34.8% | 10,426 | -2.1% | 0.01% | +25.0% |
| Q3 2020 | $770,000 | +45.0% | 10,653 | 0.0% | 0.00% | +33.3% |
| Q2 2020 | $531,000 | – | 10,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |